Truveta

Our Co-founder & CTO Jay Nanduri has been busy reflecting on Truveta's AI journey. Here, he outlines six challenges we're facing - including scaling our AI models for growth, ensuring privacy and compliance, and delivering accuracy - and the solutions we're building to tackle them: https://tr.vet/44cKd6y #AI #LargeLanguageModel #LLM #MachineLearning #ArtificialIntelligence #Innovation #HealthcareAI #HealthAI #HealthInnovation #HealthcareInnovation #HealthTech #HealthData #MedTech #HealthcareTech #HealthcareData #BigData #GenerativeAI #AIModel

In less than two weeks, we'll be at #ISPORAnnual in Atlanta. Click here to: 📽️ Learn about our theater presentation featuring our Co-founder & CMO Ryan Ahern and our partners from Moderna, 📊 Find out which studies our research team will be sharing on-site, and 🗓️ Schedule a meeting with our team during the event. https://tr.vet/43AO2Ci ISPOR—The Professional Society for Health Economics and Outcomes Research #HEOR #HealthEconomicsAndOutcomesResearch #HealthcareConference #HealthConference #HealthcareTechnology #HealthTech #HealthcareData #HealthData #ISPOR #ISPORUS

Best wishes for Khmer New Year! Last week, our team celebrated the Cambodian new year with a delicious lunch and fabulous performance. We're so grateful to our wonderful colleagues for sharing this beautiful culture and tradition. Thank you, Socheata P., Socheat Yi, Cecilia Vu, Rodolfo Inostroza, Vijeta Khatri, Preston Mar, Shoaev Hares, Annie Spencer, and Deb Nielsen! #Khmer #KhmerNewYear #CambodianNewYear #CompanyCulture #EmployeeCulture

In Truveta Research's final respiratory virus monitoring report for the 2023-2024 virus season, they cited a 32.4% decrease in respiratory virus-related hospitalizations overall in March versus February. However, infants and children actually saw a slight increase in hospitalizations month over month. Learn which of the six respiratory viruses covered in the report accounts for the largest percentage of infants' and children's hospitalizations in March: https://tr.vet/3Q9BV9N #RespiratoryViruses #Rhinovirus #Flu #Influenza #Parainfluenza #HMPV #COVID19 #COVID #RSV #PublicHealth #ClinicalCare #EHRData #MonitoringReport #HealthResearch #HealthTrends #HealthcareResearch #MedicalResearch #MedicalTrends #HospitalizationTrends #HealthcareTrends #HealthAI #HealthInnovation #HealthcareAI #HealthcareInnovation #AI #Innovation #MedTech HealthData #HealthcareData #HospitalizationData #MedicalData

“A study released on April 2 by Truveta, a health data platform, shows that 1 in 10 Americans who take Adderall have been impacted by the shortage.” Learn how findings recently cited by Truveta Research are also part of a broader plan from President Biden to address widespread medication shortages, via Business Insider: https://tr.vet/3JeXNwT #Adderall #DrugShortage #MedicationShortage #PresidentBiden #AdderallShortage #ADHD #ADHDMedication #HealthData #HealthAI #HealthInnovation #HealthcareData #HealthcareAI #HealthcareInnovation #AI #Innovation #MedicationData #MedicalData #MedicalAI #MedicalInnovation #MedTech

We're honored to have the University of Michigan Institute for Healthcare Policy & Innovation join us on our mission of Saving Lives with Data. Here's what their Data & Methods Hub Manager, Patrick Brady, MHA, had to say about our work together.

Today, we're pleased to announce that we're now working with life science organization Abbott, as well as leading academic and research orgs including the Leonard Davis Institute of Health Economics (Penn LDI), Stanford University, and the University of Michigan Institute for Healthcare Policy and Innovation. Our CEO Terry Myerson commented: “It is an honor to partner with these innovative leaders across government, life sciences, academia, and healthcare to harness the power of timely, representative, complete, and clean EHR data to accelerate research across all diseases, drugs, and devices. Using Truveta Data, these organizations will be able to pioneer groundbreaking clinical research and advance patient care.”

A new story from Business Insider reports on the Adderall supply issues over the last 18 months, which are making the medication harder to find and more expensive. Citing Truveta Research, the story notes that “1 in 10 Americans who take Adderall have been impacted by the shortage.” More on what’s being done to address the shortage: https://tr.vet/3JeXNwT Full findings from Truveta Research: https://tr.vet/49lr17y

Something to ponder heading into the weekend: In a new study, Truveta Research cited a rise in syphilis among groups typically considered low-risk between January 2019 and December 2023. Learn more: https://tr.vet/4aQBvNv #Syphilis #SyphilisTrends #STIs #SexuallyTransmittedInfections #STDs #SexuallyTransmittedDiseases #PandemicTrends #AI #Innovation #HealthAI #HealthInnovation #HealthData #HealthTech #HealthcareAI #HealthcareInnovation #HealthcareData #HealthcareTech #MedicalAI #MedicalInnovation #MedicalData #MedicalTechnology #MedTech

Truveta Research cited disparities in time to treatment, as well as treatment outcomes, for people with severe aortic stenosis receiving TAVR and SAVR procedures across SDOH factors like age, income, and geography. Learn more about their findings, classified by echocardiogram data: https://tr.vet/3x98cY2 #SDOH #SocialDeterminantsOfHealth #SocialDriversOfHealth #TAVR #SAVR #AorticStenosis #EchocardiogramData #Echocardiogram #AI #Innovation #HealthcareAI #HealthcareInnovation #HealthcareData #HealthData #HealthAI #HealthInnovation #MedicalData #MedicalAI #MedicalInnovation #MedicalTechnology #MedTech